Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Pregnancy test

Phase 2Biologic

AAssistance Publique - Hôpitaux de Paris

Pregnancy test is one of 62 biologic programs targeting Lung Cancer. It is currently in Phase 2.

3

Indications

5

Total Trials

2

Active Trials

61

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lung CancerRecruiting

CARUnknown status

HaemochromatosisCompleted

Lung CancerPhase 2

Recruiting

CARPreclinical

Unknown status

HaemochromatosisPreclinical

Completed

Competition

Competitive Landscape

199 competitors in Lung Cancer

#DrugCompanyPhaseTrials

Imfinzi

Beyfortus

Abraxane

Bristol-Myers Squibb

Alecensa

Zepzelca

Jazz Pharmaceuticals

Tarlatamab-Dznl

DATROWAY

Ilaris

Lynparza

Hycamtin

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2030

Phase 2Recruiting

Lung Cancer

NCT06620835

Clinical

Trials by Indication[1]

Systemic1 trial

Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact

Recruiting·MMedical University of Vienna·N/A·NCT05042830·30 enrolled

CAR1 trial

Determination of Carcinogens Nicotine in Electronic Cigarettes Users

Unknown status·AAssistance Publique - Hôpitaux de Paris·N/A·NCT02897401·80 enrolled

Juvenile Dermatomyositis1 trial

Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT05524311·16 enrolled

Haemochromatosis1 trial

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

Completed·RRennes University Hospital·N/A·NCT02099214·66 enrolled

Lung Cancer1 trial

Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

Recruiting·GGroupe Francais De Pneumo-Cancerologie·Phase 2·NCT06620835·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Pregnancy test. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pregnancy test compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pregnancy test. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: AAssistance Publique - Hôpitaux de Paris

Related News